"Liver cancer" trang 1 - tải miễn phí từ tailieunhanh
Baseline liver steatosis has no impact on liver metastases and overall survival in rectal cancer patients

Baseline liver steatosis has no impact on liver metastases and overall survival in rectal cancer patients
9    49    1
Does access to care play a role in liver cancer survival? The ten-year (2006–2015) experience from a population-based cancer registry in Southern Italy

Does access to care play a role in liver cancer survival? The ten-year (2006–2015) experience from a population-based cancer registry in Southern Italy
8    56    1
Colorectal liver metastases: surgery versus thermal ablation (COLLISION) – a phase III single-blind prospective randomized controlled trial

Colorectal liver metastases: surgery versus thermal ablation (COLLISION) – a phase III single-blind prospective randomized controlled trial
13    62    0
Clinical added value of MRI to CT in patients scheduled for local therapy of colorectal liver metastases (CAMINO): Study protocol for an international multicentre prospective diagnostic accuracy study

Clinical added value of MRI to CT in patients scheduled for local therapy of colorectal liver metastases (CAMINO): Study protocol for an international multicentre prospective diagnostic accuracy study
10    37    1
Diagnostic accuracy of contrast-enhanced diffusion-weighted MRI for liver metastases of pancreatic cancer: Towards adequate staging and follow-up of pancreatic cancer – DIA-PANC study: Study protocol for an international, multicenter, diagnostic trial

Diagnostic accuracy of contrast-enhanced diffusion-weighted MRI for liver metastases of pancreatic cancer: Towards adequate staging and follow-up of pancreatic cancer – DIA-PANC study: Study protocol for an international, multicenter, diagnostic trial
8    64    1
Locally ablative treatment of breast cancer liver metastases: Identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study)

Locally ablative treatment of breast cancer liver metastases: Identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study)
12    48    1
International trends in primary liver cancer incidence from 1973 to 2007

International trends in primary liver cancer incidence from 1973 to 2007
11    50    1
Computational analysis for identification of early diagnostic biomarkers and prognostic biomarkers of liver cancer based on GEO and TCGA databases and studies on pathways and biological functions affecting the survival time of liver cancer

Computational analysis for identification of early diagnostic biomarkers and prognostic biomarkers of liver cancer based on GEO and TCGA databases and studies on pathways and biological functions affecting the survival time of liver cancer
15    41    1
The trends in death of primary liver cancer caused by specifc etiologies worldwide: Results from the Global Burden of Disease Study 2019 and implications for liver cancer management

The trends in death of primary liver cancer caused by specifc etiologies worldwide: Results from the Global Burden of Disease Study 2019 and implications for liver cancer management
18    1    1
Differential in vitro effects of targeted therapeutics in primary human liver cancer: Importance for combined liver cancer

Differential in vitro effects of targeted therapeutics in primary human liver cancer: Importance for combined liver cancer
11    8    1
MicroRNA-5195-3p mediated malignant biological behaviour of insulin-resistant liver cancer cells via SOX9 and TPM4

MicroRNA-5195-3p mediated malignant biological behaviour of insulin-resistant liver cancer cells via SOX9 and TPM4
13    7    1
Research on chronic HBV infection and risk factors in patients with liver cancer in the hospital of Hue college of medicine and pharmacy

Research on chronic HBV infection and risk factors in patients with liver cancer in the hospital of Hue college of medicine and pharmacy
8    81    0
Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis

Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis
9    64    0
Eribulin-induced liver dysfunction as a prognostic indicator of survival of metastatic breast cancer patients: A retrospective study

Eribulin-induced liver dysfunction as a prognostic indicator of survival of metastatic breast cancer patients: A retrospective study
9    45    1
FOXFIRE protocol: An open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable liver-only or liver-dominant metastatic colorectal cancer

FOXFIRE protocol: An open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable liver-only or liver-dominant metastatic colorectal cancer
7    51    1
Regional differences in prostaglandin E2 metabolism in human colorectal cancer liver metastases

Regional differences in prostaglandin E2 metabolism in human colorectal cancer liver metastases
12    49    1
Serum apolipoprotein B to apolipoprotein A-I ratio is an independent predictor of liver metastasis from locally advanced rectal cancer in patients receiving neoadjuvant chemoradiotherapy plus surgery

Serum apolipoprotein B to apolipoprotein A-I ratio is an independent predictor of liver metastasis from locally advanced rectal cancer in patients receiving neoadjuvant chemoradiotherapy plus surgery
8    54    3
Establishment of metastatic liver carcinoma model by implanting AX7 cells into rabbit liver, and its histological findings

Establishment of metastatic liver carcinoma model by implanting AX7 cells into rabbit liver, and its histological findings
7    93    0
Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): A study protocol

Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): A study protocol
7    82    1
When to call it off: Defining transplant candidacy limits in liver donor liver transplantation for hepatocellular carcinoma

When to call it off: Defining transplant candidacy limits in liver donor liver transplantation for hepatocellular carcinoma
9    85    1